Intellia Therapeutics IPO: The “Biggest Biotech Discovery of the Century”

May 2, 2016, 2:58 pm EDT
Intellia Therapeutics IPO: The “Biggest Biotech Discovery of the Century”

By fits and starts, the market for initial public offerings is getting its footing. Of the four deals on tap this week, all are biotech operators. But among these offerings, there is one that is likely to stand out — Intellia Therapeutics.

Intellia plans to offer 5 million shares at a range of $16 to $18, and the lead underwriters include Credit Suisse Group AG (ADR) (CS), Jefferies and Leerink Partners. The proposed ticker stated in Intellia’s S1 form is NTLA.

The excitement for the IPO centers around Intellia’s Crispr-Cas9 technology, which is a naturally occurring defense mechanism in bacteria that fights against foreign DNA. Dr. Jennifer Doudna, a scientist at Berkeley, sees this as a way to potentially fight cancer and other diseases. Read 

The $68B Uber IPO Is DEFINITELY Not Worth the Wait

Apr 19, 2016, 10:00 am EDT

If you’ve been patiently anticipating Uber to go public, stop. It’s not coming this year, and it may not even hit the markets in 2017. Source: via Uber

In fact, just last month Uber CEO Travis Kalanick revealed in a CNBC interview that he’s trying to push Uber’s initial public offering back as far as possible, although he didn’t explicitly say why.

Well, allow me to offer up a theory: I think Uber’s delaying the inevitable IPO because it knows its private market valuation is insane — and ultimately won’t fly for very long on Wall Street. Read 

3 New Stocks to Watch This Week – MGP, ARA, SCWX

Apr 18, 2016, 2:43 pm EDT
3 New Stocks to Watch This Week – MGP, ARA, SCWX

It has been a long hibernation for IPOs, primarily because of the volatility in the markets. But now it looks like things are getting back to normal. Yes, there are three new stocks on tap for this week. Source: Flickr

If anything, there should be a hearty appetite for deals, as we got a glimpse of last week. Bats Global Markets Inc. (BATS), which operates an alternative market system for investors, pulled off a successful IPO, with the stock up 21% on Friday. The company bumped up the number of shares offered from 11.2 million to 13.3 million, which certainly was an indication of robust demand.

OK, so what are the new stocks for the week? Well, here’s a look at all of them: Read 

SecureWorks (SCWX): Get Ready for This Year’s First Tech IPO

Apr 6, 2016, 1:45 pm EDT
SecureWorks (SCWX): Get Ready for This Year’s First Tech IPO

There’s been little to write about in the IPO Playbook so far this year. But there’s good news — that should change soon with the first tech IPO of the year, SecureWorks (SCWX).

According to the Wall Street Journal, the company is gearing up for a roadshow next week. This means a SecureWorks deal is likely to come to market around April 20th to 22nd or so.

The lead underwriters include the who’s who of Wall Street, such as Bank of America Corp (BAC), Morgan Stanley (MS), Goldman Sachs Group Inc (GS) and JP Morgan Chase & Co. (JPM), among several others. The proposed ticker for SecureWorks is SCWX and the listing is planned for the Nasdaq exchange. Read 

Did Uber Just Signal the Death of This IPO Cycle?

Mar 29, 2016, 1:18 pm EDT
Did Uber Just Signal the Death of This IPO Cycle?

Nothing seems to be going right this year on the initial public offering front. In an interview with CNBC, Uber co-founder and CEO, Travis Kalanick, said that he will “make sure” that a public offering “happens as late as possible.”

No doubt, this is a big-time disappointment for IPO investors. And yes, the market has been mostly dead this year. According to Renaissance Capital, there were only eight offerings in Q1, down from 34 in the same period a year ago. The amount raised came to a paltry $700 million. In fact, the latest quarter saw the worst showing since 2009, when the global economy was mired in a financial crisis and a global recession.

OK, so why the horrible performance? For the most part, the extreme volatility in the overall markets has been the main culprit. Whenever investors get risk averse, the IPO market can seize up quickly. Read 

Square Inc: Should You Buy SQ Stock? 3 Pros, 3 Cons

Mar 8, 2016, 11:19 am EDT
Square Inc: Should You Buy SQ Stock? 3 Pros, 3 Cons

When Square Inc (SQ) went public in mid-November 2015, the initial public offering was surrounded by optimism that it would spark a comeback for tech IPOs. After all, on the debut, the stock racked up an impressive 45%.

But the good times didn’t last as the market plunged into a wrenching correction. The resulting shockwave sent Square stock from nearly $15 to $8 (keep in mind that the offering price on the IPO was $9).

Although, this was not an end to the roller coaster: As the market made a move to the upside, so did Square stock — and in an impressive way. Now the SQ stock price is $12. Not bad. Read 

1 2 3 4 241